Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 21, 2014; 20(39): 14087-14098
Published online Oct 21, 2014. doi: 10.3748/wjg.v20.i39.14087
Table 3 Effect on nonvertebral/hip fracture rates (from randomized controlled trials)
Nonvertebral
Hip
Osteoporosis (without prevalent vertebral fractures)Established osteoporosis (with prevalent vertebral fractures)Osteoporosis (without prevalent vertebral fractures)Established osteoporosis (with prevalent vertebral fractures)
RaloxifeneNANANA
AlendronateNA
RisedronateNANA
IbandronateNANANA
ZoledronateNANA
TeriparatideNANANA
Strontium Ranelate
DenosumabNANA